iSpecimen Inc. (ISPC)
NASDAQ: ISPC · Real-Time Price · USD
3.020
-0.160 (-5.03%)
Jun 5, 2026, 4:00 PM EDT - Market closed
iSpecimen Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.82 | 6.88 | 1.88 | 2.34 | 15.31 | 27.74 |
Short-Term Investments | - | - | - | 2.66 | - | - |
Cash & Short-Term Investments | 2.82 | 6.88 | 1.88 | 5.01 | 15.31 | 27.74 |
Cash Growth | 260.23% | 266.31% | -62.47% | -67.30% | -44.81% | 3886.01% |
Accounts Receivable | - | - | - | 2.94 | 3.93 | 4.74 |
Inventory | - | - | 0.05 | - | - | - |
Other Current Assets | - | - | - | 0.29 | 0.44 | 0.47 |
Total Current Assets | 2.82 | 6.88 | 1.92 | 8.24 | 19.68 | 32.95 |
Net Property, Plant & Equipment | 0.28 | 0.29 | 0.42 | 0.32 | 0.41 | 0.03 |
Other Intangible Assets | 2.84 | 2.27 | 5.33 | 7.23 | 4.5 | 2.71 |
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.03 | 0.03 | 0.03 |
Total Assets | 6.61 | 9.53 | 9.35 | 15.82 | 24.62 | 35.72 |
Accounts Payable | - | - | - | 3.93 | 2.46 | 0.83 |
Accrued Expenses | - | - | - | 1.54 | 1.53 | 1.02 |
Current Portion of Leases | - | - | - | 0.17 | 0.16 | - |
Unearned Revenue | - | - | - | 0.42 | 0.13 | 0.65 |
Total Current Liabilities | - | - | - | 6.05 | 4.28 | 2.51 |
Long-Term Debt | - | - | - | - | - | 3.42 |
Long-Term Leases | 0.2 | 0.21 | 0.27 | 0.03 | 0.03 | - |
Total Long-Term Liabilities | 0.2 | 0.21 | 0.27 | 0.03 | 0.03 | 3.42 |
Total Liabilities | 5.8 | 6.44 | 6.04 | 6.08 | 4.31 | 5.93 |
Preferred Stock | - | 0 | - | - | - | - |
Common Stock | - | - | - | 0 | 0 | 0 |
Treasury Stock | - | - | - | -0 | -0 | -0 |
Additional Paid-in Capital | 85.44 | 85.44 | 75.17 | 69.11 | 68.57 | 67.81 |
Accumulated Other Comprehensive Income | - | - | - | 0 | - | - |
Retained Earnings | -84.63 | -82.35 | -71.86 | -59.36 | -48.27 | -38.02 |
Total Common Shareholders' Equity | 0.81 | 3.09 | 3.31 | 9.74 | 20.31 | 29.79 |
Shareholders' Equity | 0.81 | 3.09 | 3.31 | 9.74 | 20.31 | 29.79 |
Total Liabilities & Equity | 6.61 | 9.53 | 9.35 | 15.82 | 24.62 | 35.72 |
Total Debt | 0.2 | 0.21 | 0.27 | 0.2 | 0.19 | 3.42 |
Net Cash (Debt) | 2.62 | 6.67 | 1.61 | 4.81 | 15.12 | 24.32 |
Net Cash Growth | -60.67% | 314.32% | -66.53% | -68.20% | -37.81% | - |
Net Cash Per Share | 14.13 | 57.96 | 90.57 | 425.54 | 1367.86 | 4537.25 |
Book Value | 0.81 | 3.09 | 3.31 | 9.74 | 20.31 | 29.79 |
Book Value Per Share | 4.38 | 26.84 | 186.31 | 861.91 | 1836.96 | 5558.88 |
Tangible Book Value | -2.02 | 0.82 | -2.02 | 2.51 | 15.81 | 27.08 |
Tangible Book Value Per Share | -10.89 | 7.11 | -113.53 | 222.07 | 1429.59 | 5053.05 |